![Roni Mamluk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roni Mamluk
Directeur/Bestuurslid bij
REDHILL BIOPHARMA LTD.
Vermogen: 3 M $ op 31-05-2026
Profiel
Roni Mamluk currently works at RedHill Biopharma Ltd., as Independent Director from 2024 and Israel Biotech Fund, as Venture Advisor.
Dr. Mamluk also formerly worked at Old Ayala, Inc., as President, Chief Executive Officer & Director, Chiasma, Inc., as Independent Director from 2017 to 2021, Chiasma (Israel) Ltd., as Director from 2017 to 2021, Amryt Pharma Holdings Ltd., as Non-Executive Director, Amryt Pharma Ltd., as Non-Executive Director from 2021 to 2023, and Adnexus, as Head-Non Clinical Research & Development.
Dr. Mamluk received her undergraduate degree and doctorate degree from The Hebrew University of Jerusalem and graduate degree in 2004 from Harvard Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-04-2026 | 28.120.000 ( 0,05% ) | 3 M $ | 31-05-2026 |
Actieve functies van Roni Mamluk
| Bedrijven | Functie | Begin |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Directeur/Bestuurslid | 01-09-2024 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultant / Adviseur | - |
Eerdere bekende functies van Roni Mamluk
| Bedrijven | Functie | Einde |
|---|---|---|
| ADVAXIS, INC. | Algemeen Directeur | 19-01-2023 |
| AMRYT PHARMA PLC | Directeur/Bestuurslid | 01-01-2023 |
Chiasma (Israel) Ltd. | Directeur/Bestuurslid | 01-08-2021 |
| CHIASMA, INC. | Algemeen Directeur | 17-06-2015 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Directeur/Bestuurslid | - |
Opleiding van Roni Mamluk
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
66
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiasma (Israel) Ltd. | |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RedHill Biopharma Ltd.
 RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
